Investigational Drug Information for Eleclazine
✉ Email this page to a colleague
What is the development status for investigational drug Eleclazine?
Eleclazine is an investigational drug.
There have been 6 clinical trials for Eleclazine.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 17th 2014.
The most common disease conditions in clinical trials are Long QT Syndrome, Syndrome, and Hypertrophy. The leading clinical trial sponsors are Gilead Sciences and [disabled in preview].
There are ten US patents protecting this investigational drug and one hundred and sixty international patents.
Summary for Eleclazine
| US Patents | 10 |
| International Patents | 160 |
| US Patent Applications | 40 |
| WIPO Patent Applications | 17 |
| Japanese Patent Applications | 7 |
| Clinical Trial Progress | Phase 2 (2014-12-17) |
| Vendors | 33 |
Recent Clinical Trials for Eleclazine
| Title | Sponsor | Phase |
|---|---|---|
| Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome | Gilead Sciences | Phase 1 |
| Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function | Gilead Sciences | Phase 1 |
| Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function | Gilead Sciences | Phase 1 |
Clinical Trial Summary for Eleclazine
Top disease conditions for Eleclazine
Top clinical trial sponsors for Eleclazine
US Patents for Eleclazine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Eleclazine | ⤷ Try a Trial | Fused heterocyclic compounds as CaM kinase inhibitors | Gilead Sciences, Inc. (Foster City, CA) | ⤷ Try a Trial |
| Eleclazine | ⤷ Try a Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try a Trial |
| Eleclazine | ⤷ Try a Trial | Fused heterocyclic compounds as ion channel modulators | Gilead Sciences, Inc. (Foster City, CA) | ⤷ Try a Trial |
| Eleclazine | ⤷ Try a Trial | Fused heterocyclic compounds as ion channel modulators | Gilead Sciences, Inc. (Foster City, CA) | ⤷ Try a Trial |
| Eleclazine | ⤷ Try a Trial | Methods of treating hypertrophic cardiomyopathy | Gilead Sciences, Inc. (Foster City, CA) | ⤷ Try a Trial |
| Eleclazine | ⤷ Try a Trial | Compound and methods for treating long QT syndrome | Gilead Sciences, Inc. (Foster City, CA) | ⤷ Try a Trial |
| Eleclazine | ⤷ Try a Trial | Fused heterocyclic compounds as ion channel modulators | Gilead Sciences, Inc. (Foster City, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Eleclazine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Eleclazine | Argentina | AR110252 | 2036-11-30 | ⤷ Try a Trial |
| Eleclazine | European Patent Office | EP3548495 | 2036-11-30 | ⤷ Try a Trial |
| Eleclazine | Spain | ES2861382 | 2036-11-30 | ⤷ Try a Trial |
| Eleclazine | Taiwan | TW201831487 | 2036-11-30 | ⤷ Try a Trial |
| Eleclazine | Taiwan | TWI651325 | 2036-11-30 | ⤷ Try a Trial |
| Eleclazine | World Intellectual Property Organization (WIPO) | WO2018102384 | 2036-11-30 | ⤷ Try a Trial |
| Eleclazine | Australia | AU2017261372 | 2036-05-05 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
